Shenzhen - Delayed Quote CNY
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)
11.25
-0.43
(-3.68%)
At close: April 25 at 3:04:12 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,102,853.14
1,186,786
1,028,413.62
945,799.42
1,338,882.99
Cost of Revenue
539,184.07
476,380.10
365,572.46
309,384.88
491,300.83
Gross Profit
563,669.07
710,405.90
662,841.16
636,414.54
847,582.16
Operating Expense
538,961.24
693,357.20
679,551.27
765,235.65
786,472.80
Operating Income
24,707.83
17,048.70
-16,710.11
-128,821.11
61,109.37
Net Non Operating Interest Income Expense
90.95
3,836.86
4,751.03
-2,775.22
2,925.42
Pretax Income
57,529.78
81,374.43
40,069.61
452,855.81
33,157.12
Tax Provision
7,411.25
11,295.32
13,569.71
103,178.17
6,523.91
Net Income Common Stockholders
54,122.06
73,663.11
30,207.31
350,951.06
29,324.80
Basic EPS
0.18
0.24
0.10
1.13
0.09
Diluted EPS
0.18
0.24
0.10
1.13
0.09
Basic Average Shares
303,730.24
306,929.63
302,073.12
310,576.16
325,831.13
Diluted Average Shares
303,730.24
306,929.63
302,073.12
310,576.16
325,831.13
Total Operating Income as Reported
56,971.33
79,021.87
40,629.15
454,805.43
35,264.35
Rent Expense Supplemental
--
8,095.71
6,306.27
6,566.88
8,239.17
Total Expenses
1,078,145.31
1,169,737.30
1,045,123.73
1,074,620.53
1,277,773.63
Net Income from Continuing & Discontinued Operation
54,122.06
73,663.11
30,207.31
350,951.06
29,324.80
Normalized Income
56,800.35
61,286.22
26,840.93
360,137.87
62,848.03
Interest Income
26,224.23
27,912.42
28,285.98
11,819.48
10,029.45
Interest Expense
28,585.08
22,890.21
22,598.39
13,802.96
9,326.47
Net Interest Income
90.95
3,836.86
4,751.03
-2,775.22
2,925.42
EBIT
86,114.86
104,264.64
62,668
466,658.77
42,483.59
EBITDA
86,114.86
212,940.38
169,236.03
565,790.55
122,430.30
Reconciled Cost of Revenue
539,184.07
476,380.10
365,572.46
309,384.88
491,300.83
Reconciled Depreciation
--
108,675.73
106,568.03
99,131.78
79,946.71
Net Income from Continuing Operation Net Minority Interest
54,122.06
73,663.11
30,207.31
350,951.06
29,324.80
Total Unusual Items Excluding Goodwill
-3,074.34
14,371.79
5,090.19
-11,897.53
-41,734.88
Total Unusual Items
-3,074.34
14,371.79
5,090.19
-11,897.53
-41,734.88
Normalized EBITDA
89,189.20
198,568.58
164,145.84
577,688.08
164,165.18
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-396.05
1,994.90
1,723.81
-2,710.72
-8,211.64
12/31/2020 - 9/25/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade